Pelthos Therapeutics (PTHS) Return on Invested Capital [ROIC] (2026)
Pelthos Therapeutics (PTHS) recorded Return on Invested Capital [ROIC] of -150.54% in Q2 2026, down 57.49 percentage points from the prior quarter.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Return on Invested Capital [ROIC] (2026) Analysis & Trends
For FY2025, Pelthos Therapeutics reported Return on Invested Capital [ROIC] of -143.98%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 34.87% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 23.26% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 13.44% |
| 10 | Pelthos Therapeutics | 63.29 Mn | -25.10 Mn | 11.99 Mn | -150.54% |
API Access
Pelthos Therapeutics Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=PTHS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "PTHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=PTHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();